COVID-19:目前的治疗策略

Ketki Kalele, R. Gondhalekar
{"title":"COVID-19:目前的治疗策略","authors":"Ketki Kalele, R. Gondhalekar","doi":"10.18231/j.jooo.2020.001","DOIUrl":null,"url":null,"abstract":"Outbreak of Coronavirus pandemic (COVID-19) in Wuhan, China in December 2019 has become a major health emergency of international concern & millions of people around the globe have been affected by the viral infection. Looking at the magnitude and severity of the disease, scientist’s world wide are tirelessly working for some therapeutic breakthroughs in this arena. However, till date there has been no sure shot remedy for this highly infective disease. The novel corona virus (SARS‐CoV‐2) has crossed the species barriers and has infected humans; which has caused millions of people getting affected by the infection. Multiple factors make this virus difficult to treat and prevent, one of the reason for it is difficulty in tracing the intermediate host in the actual origin of the virus. Understanding of the basic structural binding mechanism of the virus to the host gives the clue for varied range of hosts that the virus may bind to (virus reservoirs). This will further lead us to design countermeasure against the virus. A cryoelectron microscopic study done by Wrapp D et al. has reported that that the binding capacity of SARS‐CoV‐2 S protein to ACE2 which is human surface receptor is much stronger than that of SARS‐CoV, which shows that there are more intermediate hosts for SARS‐CoV‐2. Liu et al. in their article has stated that From SARS‐CoV and MERS‐CoV to SARS‐CoV‐2, all point to bats as the natural host of coronaviruses, but the intermediate hosts for all are different. The article points at snakes, turtles to be more likely & pangolins or civattes for less likely being the intermediates for SARS‐CoV‐2. This article aims to summarize all the drugs and therapies that are presently under consideration and also under trials for the treatment of the disease. Some of the treatment modalities that are currently in use are-","PeriodicalId":16606,"journal":{"name":"Journal of oral medicine","volume":"25 1","pages":"1-2"},"PeriodicalIF":0.0000,"publicationDate":"2020-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"COVID-19: Current treatment strategies\",\"authors\":\"Ketki Kalele, R. Gondhalekar\",\"doi\":\"10.18231/j.jooo.2020.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Outbreak of Coronavirus pandemic (COVID-19) in Wuhan, China in December 2019 has become a major health emergency of international concern & millions of people around the globe have been affected by the viral infection. Looking at the magnitude and severity of the disease, scientist’s world wide are tirelessly working for some therapeutic breakthroughs in this arena. However, till date there has been no sure shot remedy for this highly infective disease. The novel corona virus (SARS‐CoV‐2) has crossed the species barriers and has infected humans; which has caused millions of people getting affected by the infection. Multiple factors make this virus difficult to treat and prevent, one of the reason for it is difficulty in tracing the intermediate host in the actual origin of the virus. Understanding of the basic structural binding mechanism of the virus to the host gives the clue for varied range of hosts that the virus may bind to (virus reservoirs). This will further lead us to design countermeasure against the virus. A cryoelectron microscopic study done by Wrapp D et al. has reported that that the binding capacity of SARS‐CoV‐2 S protein to ACE2 which is human surface receptor is much stronger than that of SARS‐CoV, which shows that there are more intermediate hosts for SARS‐CoV‐2. Liu et al. in their article has stated that From SARS‐CoV and MERS‐CoV to SARS‐CoV‐2, all point to bats as the natural host of coronaviruses, but the intermediate hosts for all are different. The article points at snakes, turtles to be more likely & pangolins or civattes for less likely being the intermediates for SARS‐CoV‐2. This article aims to summarize all the drugs and therapies that are presently under consideration and also under trials for the treatment of the disease. Some of the treatment modalities that are currently in use are-\",\"PeriodicalId\":16606,\"journal\":{\"name\":\"Journal of oral medicine\",\"volume\":\"25 1\",\"pages\":\"1-2\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-04-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of oral medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18231/j.jooo.2020.001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of oral medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18231/j.jooo.2020.001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

2019年12月在中国武汉爆发的冠状病毒大流行(COVID-19)已成为国际关注的重大突发卫生事件,全球数百万人受到病毒感染。鉴于这种疾病的规模和严重性,全世界的科学家都在不知疲倦地努力在这一领域取得一些治疗上的突破。然而,到目前为止,还没有确定的疫苗治疗这种高度传染性疾病。新型冠状病毒(SARS - CoV - 2)已跨越物种障碍并感染人类;这导致数百万人受到感染。多种因素使该病毒难以治疗和预防,其中一个原因是难以追踪病毒的实际起源中的中间宿主。了解病毒与宿主的基本结构结合机制,为病毒可能结合的不同宿主(病毒库)提供了线索。这将进一步引导我们设计对抗病毒的对策。Wrapp D等人的低温电镜研究报道,SARS‐CoV‐2 S蛋白与人表面受体ACE2的结合能力比SARS‐CoV的结合能力强得多,这表明SARS‐CoV‐2有更多的中间宿主。Liu等人在他们的文章中指出,从SARS - CoV和MERS - CoV到SARS - CoV - 2,都指出蝙蝠是冠状病毒的天然宿主,但它们的中间宿主是不同的。文章指出蛇、海龟更有可能是SARS - CoV - 2的中间媒介,而穿山甲或麝香猫的可能性较小。这篇文章的目的是总结所有的药物和治疗方法,目前正在考虑和试验中治疗这种疾病。目前使用的一些治疗方式是
本文章由计算机程序翻译,如有差异,请以英文原文为准。
COVID-19: Current treatment strategies
Outbreak of Coronavirus pandemic (COVID-19) in Wuhan, China in December 2019 has become a major health emergency of international concern & millions of people around the globe have been affected by the viral infection. Looking at the magnitude and severity of the disease, scientist’s world wide are tirelessly working for some therapeutic breakthroughs in this arena. However, till date there has been no sure shot remedy for this highly infective disease. The novel corona virus (SARS‐CoV‐2) has crossed the species barriers and has infected humans; which has caused millions of people getting affected by the infection. Multiple factors make this virus difficult to treat and prevent, one of the reason for it is difficulty in tracing the intermediate host in the actual origin of the virus. Understanding of the basic structural binding mechanism of the virus to the host gives the clue for varied range of hosts that the virus may bind to (virus reservoirs). This will further lead us to design countermeasure against the virus. A cryoelectron microscopic study done by Wrapp D et al. has reported that that the binding capacity of SARS‐CoV‐2 S protein to ACE2 which is human surface receptor is much stronger than that of SARS‐CoV, which shows that there are more intermediate hosts for SARS‐CoV‐2. Liu et al. in their article has stated that From SARS‐CoV and MERS‐CoV to SARS‐CoV‐2, all point to bats as the natural host of coronaviruses, but the intermediate hosts for all are different. The article points at snakes, turtles to be more likely & pangolins or civattes for less likely being the intermediates for SARS‐CoV‐2. This article aims to summarize all the drugs and therapies that are presently under consideration and also under trials for the treatment of the disease. Some of the treatment modalities that are currently in use are-
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信